COVID-19 vaccine available in March

22 February 2024 - Joint media release with Health New Zealand. ...

Read more →

MHRA approvals for Comirnaty (Pfizer/BioNTech) and Nuvaxovid (Novavax) COVID-19 vaccines

10 February 2024 - Approval of a change to the licence of Comirnaty COVID-19 vaccine will enable thawing and re-labelling of ...

Read more →

Remdesivir and the combination of tixagevimab and cilgavimab for the treatment of patients with COVID-19 disease

18 January 2024 - NICE has published additional draft guidance on the use of remdesivir and the combination of tixagevimab ...

Read more →

NICE issues draft guidance for use of remdesivir and also for tixagevimab-cilgavimab for treatment of COVID-19

18 January 2024 - Draft guidance for public consultation has been published by NICE. ...

Read more →

1.4 million more people at risk of severe COVID-19 to have access to antiviral Paxlovid

11 January 2024 - A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be ...

Read more →

Application for COVID-19 vaccine Nuvaxovid against Omicron variant XBB.1.5 withdrawn

18 December 2023 - The manufacturer Novavax is no longer pursuing marketing authorisation for its COVID-19 vaccine in Switzerland. ...

Read more →

Future supply of new COVID-19 vaccines confirmed

20 December 2023 - A vaccine to combat the newer strains of COVID-19 has been approved and will be available ...

Read more →

Texas makes a stand against big pharma’s Covid vaccines

19 December 2023 - On the last day of November Texas launched extraordinary legal proceedings that could have wide-ranging political ...

Read more →

Evolving our approach to COVID-19 vaccines and treatments

6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours. ...

Read more →

EU medicines agencies reflect on lessons learned from COVID-19

1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...

Read more →

Japan's Ministry of Health, Labour and Welfare approves CSL and Arcturus Therapeutics' ARCT-154, the first self-amplifying mRNA vaccine approved for COVID in adults

27 November 2023 - Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approval. ...

Read more →

Daichirona for intramuscular injection for booster vaccination approved in Japan as Omicron XBB.1.5 adapted monovalent mRNA vaccine against COVID-19

28 November 2023 - - Daiichi Sankyo today announced that Daichirona for intramuscular injection (DS-5670) for booster vaccination has been ...

Read more →

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

20 November 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation on the use of XBB 1.5 COVID-19 vaccines. ...

Read more →

New Covid-19 vaccines available to target current variants

20 November 2023 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation on ...

Read more →

EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5

31 October 2023 - The EMA’s CHMP has recommended authorising an adapted Nuvaxovid vaccine targeting the Omicron XBB.1.5 subvariant of ...

Read more →